DE3881939D1 - Verwendung von ofloxacin zur lokalen behandlung oder prophylaxe von beschwerden der wurzelhaut der zaehne. - Google Patents

Verwendung von ofloxacin zur lokalen behandlung oder prophylaxe von beschwerden der wurzelhaut der zaehne.

Info

Publication number
DE3881939D1
DE3881939D1 DE8888102579T DE3881939T DE3881939D1 DE 3881939 D1 DE3881939 D1 DE 3881939D1 DE 8888102579 T DE8888102579 T DE 8888102579T DE 3881939 T DE3881939 T DE 3881939T DE 3881939 D1 DE3881939 D1 DE 3881939D1
Authority
DE
Germany
Prior art keywords
ofloxacin
complaints
prophylaxis
roots
teeth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888102579T
Other languages
English (en)
Other versions
DE3881939T2 (de
Inventor
Shigeru Kametaka
Tadaaki Miyazaki
Shinichi Hayashi
Akira Handa
Kinya Kameda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
ROHTO PHARMACEUTICAL CO Ltd OSAKA JP
Daiichi Pharmaceutical Co Ltd
Rohto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROHTO PHARMACEUTICAL CO Ltd OSAKA JP, Daiichi Pharmaceutical Co Ltd, Rohto Pharmaceutical Co Ltd filed Critical ROHTO PHARMACEUTICAL CO Ltd OSAKA JP
Application granted granted Critical
Publication of DE3881939D1 publication Critical patent/DE3881939D1/de
Publication of DE3881939T2 publication Critical patent/DE3881939T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE88102579T 1987-02-26 1988-02-22 Verwendung von Ofloxacin zur lokalen Behandlung oder Prophylaxe von Beschwerden der Wurzelhaut der Zähne. Expired - Fee Related DE3881939T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4339187 1987-02-26

Publications (2)

Publication Number Publication Date
DE3881939D1 true DE3881939D1 (de) 1993-07-29
DE3881939T2 DE3881939T2 (de) 1993-09-30

Family

ID=12662494

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88102579T Expired - Fee Related DE3881939T2 (de) 1987-02-26 1988-02-22 Verwendung von Ofloxacin zur lokalen Behandlung oder Prophylaxe von Beschwerden der Wurzelhaut der Zähne.

Country Status (9)

Country Link
US (1) US4965262A (de)
EP (1) EP0286802B1 (de)
JP (1) JP2619257B2 (de)
KR (1) KR940002666B1 (de)
AU (1) AU608570B2 (de)
CA (1) CA1310916C (de)
DE (1) DE3881939T2 (de)
PH (1) PH24459A (de)
ZA (1) ZA881318B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
KR960016882A (ko) * 1994-11-01 1996-06-17 강재헌 치주염치료를 위한 서방출형 생분해성 제제
US5686095A (en) * 1995-10-23 1997-11-11 Price, Jr.; Francis W. Method of treating canker sores
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
JP4653282B2 (ja) * 2000-05-23 2011-03-16 昭和薬品化工株式会社 ミノサイクリン含有組成物
WO2010131054A1 (en) 2009-05-15 2010-11-18 Bradford Pharma Limited Redox drug derivatives

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984548A (en) * 1974-02-11 1976-10-05 Riker Laboratories, Inc. Substituted pyrido[1,2,3,-de]-1,4-benzoxazines as bactericides
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS5862113A (ja) * 1981-10-08 1983-04-13 Dai Ichi Seiyaku Co Ltd 抗酸菌活性薬剤
JPS5872588A (ja) * 1981-10-27 1983-04-30 Dai Ichi Seiyaku Co Ltd ピリド〔１，２，３−ｄｅ〕−１，４−ベンゾオキサジン誘導体の製造法
JPS58210092A (ja) * 1982-05-31 1983-12-07 Dai Ichi Seiyaku Co Ltd ピリドベンズオキサジン誘導体およびその製造法
US4551456A (en) * 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
JPS60130510A (ja) * 1983-12-20 1985-07-12 Lion Corp 口腔用組成物
US4701320A (en) * 1984-11-29 1987-10-20 Lederle (Japan), Ltd. Composition stably containing minocycline for treating periodontal diseases
JPS61148125A (ja) * 1984-12-21 1986-07-05 Sunstar Inc 歯周疾患治療剤
EP0200508B1 (de) * 1985-04-27 1991-10-02 Nitto Denko Corporation Klebepflaster und Arzneimittel für die Mundhöhle
DE3522406A1 (de) * 1985-06-22 1987-01-02 Bayer Ag Verfahren zur herstellung von 1,8-verbrueckten 4-chinolon-3-carbonsaeuren
JP2558107B2 (ja) * 1986-12-18 1996-11-27 第一製薬株式会社 外用剤
CA1309024C (en) * 1986-12-19 1992-10-20 Hiromitsu Seki Aqueous pharmaceutical composition containing s-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl -7-oxo-2,3,-dihydro-7h-pyridol[1,2,3,-de][1,4]benzoxazine -6-carboxylic acid

Also Published As

Publication number Publication date
AU608570B2 (en) 1991-04-11
JPH01110628A (ja) 1989-04-27
AU1218488A (en) 1988-09-01
EP0286802B1 (de) 1993-06-23
ZA881318B (en) 1988-08-29
US4965262A (en) 1990-10-23
PH24459A (en) 1990-06-25
KR940002666B1 (ko) 1994-03-28
DE3881939T2 (de) 1993-09-30
JP2619257B2 (ja) 1997-06-11
EP0286802A3 (de) 1992-01-08
CA1310916C (en) 1992-12-01
EP0286802A2 (de) 1988-10-19
KR880009656A (ko) 1988-10-04

Similar Documents

Publication Publication Date Title
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
DE3581514D1 (de) Film zur behandlung von halbleiterwaffeln.
ATE384703T1 (de) Piperazinyl-substituierte phenylpyrimidinderivative zur behandlung oder vorbeugung von zns erkrankungen
DE3788739D1 (de) Oxadiazole zur Verwendung in der Behandlung von Dementia Senilis.
DE3683318D1 (de) Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege.
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
ATE110556T1 (de) Verbesserungen bei der behandlung von zähnen.
DE69004081D1 (de) Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
DE3482754D1 (de) Medikament und medikamentoese zusammensetzung zur behandlung und/oder verhinderung von hautkrankheiten, verursacht durch eine entzuendung.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE3788057D1 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
DE3483330D1 (de) Mittel zur behandlung von erkrankungen der zahnwurzelhaut.
DE3782028D1 (de) Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen.
DE3888994D1 (de) Behandlung von androgener Alopecia mit 17-beta-n-mono-substituierten-carbamoyl-4-aza-5-alpha-androst-1-en-3-onen.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
DE3881939D1 (de) Verwendung von ofloxacin zur lokalen behandlung oder prophylaxe von beschwerden der wurzelhaut der zaehne.
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
DE3586420D1 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
DE3785555D1 (de) Verwendung von guaifenesin zur behandlung urologischer beschwerden.
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
DE3486005D1 (de) Anwendung von carbamate oder thiocarbamat-derivaten zur behandlung von fungus-infektionen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI PHARMACEUTICAL CO., LTD., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee